Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study-Reference-Cited by-同舟云学术

Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study

Published:2017-09-12 Issue:6 Volume:39 Page:1256-1264
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Khan Qasim,Ismail Mohammad^ORCID,Haider Iqbal,Khan Fahadullah

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

http://link.springer.com/article/10.1007/s11096-017-0532-5/fulltext.html

Reference46 articles.

1. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–7.

2. Armahizer MJ, Seybert AL, Smithburger PL, Kane-Gill SL. Drug–drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care. 2013;28:243–9.

3. Roden DM. Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes. Pacing Clin Electrophysiol. 1998;21:1029–34.

4. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Circ Res. 1985;56:857–67.

5. Sicouri S, Antzelevitch C. Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cells (M cells) in the canine heart: quinidine and digitalis. J Cardiovasc Electrophysiol. 1993;4:48–58.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Arrhythmia in the Elderly Patients on Combination Therapy of CYP3A4 Substrates and Inhibitors with the Korean Claims Data;Korean Journal of Clinical Pharmacy;2023-12-31

2. Drug therapy problems in patients with schizophrenia: A cross-sectional study;Clinical Medicine Insights: Psychiatry;2023-04

3. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021;Medicina;2023-02-01

4. Determinação do risco potencial de interações medicamentosas prolongadoras do intervalo QT em idosos internados em unidade de terapia intensiva;Revista Colombiana de Ciencias Químico-Farmacéuticas;2022-10-29

5. Prevalence of QT-Prolonging Drug-Drug Interactions in Psychiatry: A Systematic Review and Meta Analysis;Journal of Pharmacy Practice;2022-08-14